Japan’s Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

Investing.com Gold reports: Japan’s Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds. Full body text was unavailable at ingest time, so this brief is based on headline context.